10-K Filing

MOLINA HEALTHCARE, INC. CIK: 1179929 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001179929-21-000024`
Period End Date	20201231
Filing Date	20210216
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	moh-20201231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 57 Cash Flow Statement 167 Stockholders Equity 32 Comprehensive Income 15

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.83B	USD	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	59.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.15B	USD	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	62.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.45B	USD	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$1.95B	USD	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$1.88B	USD	Point-in-time
Preferred stock, par value (dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Receivables	`ReceivablesNetCurrent`	$1.41B	USD	Point-in-time
Receivables	`ReceivablesNetCurrent`	$1.67B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$163.00M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$175.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.88B	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$5.97B	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$385.00M	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$391.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$941.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$172.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$79.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$136.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$69.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$79.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$105.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$119.00M	USD	Point-in-time
Total assets	`Assets`	$9.53B	USD	Point-in-time
Total assets	`Assets`	$6.79B	USD	Point-in-time
Total assets	`Assets`	$7.15B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.85B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.96B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$2.19B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$2.70B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$1.25B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$664.00M	USD	Point-in-time
Accounts payable, accrued liabilities and other	`AccountsPayableAndAccruedLiabilitiesCurrent`	$502.00M	USD	Point-in-time
Accounts payable, accrued liabilities and other	`AccountsPayableAndAccruedLiabilitiesCurrent`	$641.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$375.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$249.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.27B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.96B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.24B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.13B	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$231.00M	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$225.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$90.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$119.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.44B	USD	Point-in-time
Total liabilities	`Liabilities`	$4.83B	USD	Point-in-time
Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019	`CommonStockValueOutstanding`	-	USD	Point-in-time
Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 59 million shares at December 31, 2020, and 62 million at December 31, 2019	`CommonStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$175.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$199.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$4.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$37.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.86B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.78B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.96B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.34B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.65B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.10B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$9.53B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$6.79B	USD	Point-in-time

Income Statement 57 line items

Line Item	Tag	Value	Unit	Period
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$132.00M	USD	Annual
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$76.00M	USD	Annual
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$125.00M	USD	Annual
Total revenue	`Revenues`	$19.42B	USD	Annual
Total revenue	`Revenues`	$16.83B	USD	Annual
Total revenue	`Revenues`	$18.89B	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.30B	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.48B	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.33B	USD	Annual
Premium tax expenses	`PremiumTaxExpenses`	$417.00M	USD	Annual
Premium tax expenses	`PremiumTaxExpenses`	$489.00M	USD	Annual
Premium tax expenses	`PremiumTaxExpenses`	$649.00M	USD	Annual
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	$348.00M	USD	Annual
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	-	USD	Annual
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	$277.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$89.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$99.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$88.00M	USD	Annual
Other	`OtherCostAndExpenseOperating`	$6.00M	USD	Annual
Other	`OtherCostAndExpenseOperating`	$61.00M	USD	Annual
Other	`OtherCostAndExpenseOperating`	$31.00M	USD	Annual
Total operating expenses	`CostsAndExpenses`	$18.34B	USD	Annual
Total operating expenses	`CostsAndExpenses`	$17.76B	USD	Annual
Total operating expenses	`CostsAndExpenses`	$15.79B	USD	Annual
Operating income	`OperatingIncomeLoss`	$1.04B	USD	Annual
Operating income	`OperatingIncomeLoss`	$1.08B	USD	Annual
Operating income	`OperatingIncomeLoss`	$1.13B	USD	Annual
Interest expense	`InterestExpense`	$102.00M	USD	Annual
Interest expense	`InterestExpense`	$115.00M	USD	Annual
Interest expense	`InterestExpense`	$87.00M	USD	Annual
Other expenses (income), net	`OtherNonoperatingIncomeExpense`	$-17.00M	USD	Annual
Other expenses (income), net	`OtherNonoperatingIncomeExpense`	$-15.00M	USD	Annual
Other expenses (income), net	`OtherNonoperatingIncomeExpense`	$15.00M	USD	Annual
Total other expenses, net	`NonoperatingIncomeExpense`	$-72.00M	USD	Annual
Total other expenses, net	`NonoperatingIncomeExpense`	$-132.00M	USD	Annual
Total other expenses, net	`NonoperatingIncomeExpense`	$-117.00M	USD	Annual
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$999.00M	USD	Annual
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$972.00M	USD	Annual
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$961.00M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$235.00M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$288.00M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$292.00M	USD	Annual
Net income	`NetIncomeLoss`	$707.00M	USD	Annual
Net income	`NetIncomeLoss`	$673.00M	USD	Annual
Net income	`NetIncomeLoss`	$737.00M	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$11.40	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$11.85	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$11.57	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$10.61	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$11.23	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$11.47	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	59.00M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	61.10M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	62.20M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	66.60M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	64.20M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	59.90M	shares	Annual

Cash Flow Statement 167 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$673.00M	USD	Annual
Net income	`NetIncomeLoss`	$737.00M	USD	Annual
Net income	`NetIncomeLoss`	$707.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$89.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$127.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$88.00M	USD	Annual
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$19.00M	USD	Annual
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$6.00M	USD	Annual
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-10.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$39.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$57.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$27.00M	USD	Annual
Loss (gain) on debt repayment	`GainLossOnDebtRepayment`	$15.00M	USD	Annual
Loss (gain) on debt repayment	`GainLossOnDebtRepayment`	$-22.00M	USD	Annual
Loss (gain) on debt repayment	`GainLossOnDebtRepayment`	$-15.00M	USD	Annual
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	Annual
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	Annual
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	$-15.00M	USD	Annual
Non-cash restructuring charges	`NoncashRestructuringCharges`	-	USD	Annual
Non-cash restructuring charges	`NoncashRestructuringCharges`	-	USD	Annual
Non-cash restructuring charges	`NoncashRestructuringCharges`	$17.00M	USD	Annual
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$12.00M	USD	Annual
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$26.00M	USD	Annual
Other, net	`OtherOperatingActivitiesCashFlowStatement`	-	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$530.00M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$76.00M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$100.00M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-28.00M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-6.00M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$16.00M	USD	Annual
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$544.00M	USD	Annual
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$-107.00M	USD	Annual
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$-226.00M	USD	Annual
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$-303.00M	USD	Annual
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$446.00M	USD	Annual
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$-574.00M	USD	Annual
Accounts payable, accrued liabilities and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$45.00M	USD	Annual
Accounts payable, accrued liabilities and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$78.00M	USD	Annual
Accounts payable, accrued liabilities and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.00M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-21.00M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$38.00M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$126.00M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-15.00M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-14.00M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$51.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-314.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$427.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.89B	USD	Annual
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$2.54B	USD	Annual
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$670.00M	USD	Annual
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$1.44B	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.44B	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.30B	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.10B	USD	Annual
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$74.00M	USD	Annual
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$57.00M	USD	Annual
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$30.00M	USD	Annual
Net cash paid in business combinations	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$755.00M	USD	Annual
Net cash paid in business combinations	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Net cash paid in business combinations	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Net cash received from sale of subsidiaries	`ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates`	-	USD	Annual
Net cash received from sale of subsidiaries	`ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates`	-	USD	Annual
Net cash received from sale of subsidiaries	`ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates`	$190.00M	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$2.00M	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$18.00M	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-2.00M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-293.00M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.14B	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-400.00M	USD	Annual
Proceeds from senior notes offerings, net of issuance costs	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$1.43B	USD	Annual
Proceeds from senior notes offerings, net of issuance costs	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	Annual
Proceeds from senior notes offerings, net of issuance costs	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	Annual
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	$47.00M	USD	Annual
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	$606.00M	USD	Annual
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Repayment of term loan facility	`RepaymentsOfLongTermLinesOfCredit`	$600.00M	USD	Annual
Repayment of term loan facility	`RepaymentsOfLongTermLinesOfCredit`	-	USD	Annual
Repayment of term loan facility	`RepaymentsOfLongTermLinesOfCredit`	-	USD	Annual
Proceeds from borrowings under term loan facility	`ProceedsFromLinesOfCredit`	-	USD	Annual
Proceeds from borrowings under term loan facility	`ProceedsFromLinesOfCredit`	$380.00M	USD	Annual
Proceeds from borrowings under term loan facility	`ProceedsFromLinesOfCredit`	$220.00M	USD	Annual
Repayment of senior notes	`RepaymentsOfSeniorDebt`	-	USD	Annual
Repayment of senior notes	`RepaymentsOfSeniorDebt`	$338.00M	USD	Annual
Repayment of senior notes	`RepaymentsOfSeniorDebt`	-	USD	Annual
Cash paid for partial termination of warrants	`PaymentsForRepurchaseOfWarrants`	$549.00M	USD	Annual
Cash paid for partial termination of warrants	`PaymentsForRepurchaseOfWarrants`	$514.00M	USD	Annual
Cash paid for partial termination of warrants	`PaymentsForRepurchaseOfWarrants`	$30.00M	USD	Annual
Cash paid for partial settlement of conversion option	`CashPaidForSettlementOfConversionOption`	$27.00M	USD	Annual
Cash paid for partial settlement of conversion option	`CashPaidForSettlementOfConversionOption`	$578.00M	USD	Annual
Cash paid for partial settlement of conversion option	`CashPaidForSettlementOfConversionOption`	$623.00M	USD	Annual
Cash received for partial settlement of call option	`ProceedsFromConvertibleDebt`	$578.00M	USD	Annual
Cash received for partial settlement of call option	`ProceedsFromConvertibleDebt`	$27.00M	USD	Annual
Cash received for partial settlement of call option	`ProceedsFromConvertibleDebt`	$623.00M	USD	Annual
Repayment of principal amount of convertible senior notes	`RepaymentsOfConvertibleDebt`	$362.00M	USD	Annual
Repayment of principal amount of convertible senior notes	`RepaymentsOfConvertibleDebt`	$240.00M	USD	Annual
Repayment of principal amount of convertible senior notes	`RepaymentsOfConvertibleDebt`	$12.00M	USD	Annual
Repayment of credit facility	`RepaymentsOfLinesOfCredit`	$300.00M	USD	Annual
Repayment of credit facility	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Repayment of credit facility	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$2.00M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$29.00M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$18.00M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$225.00M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.19B	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-552.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.72B	USD	Annual
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-364.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-418.00M	USD	Annual
Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.51B	USD	Point-in-time
Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29B	USD	Point-in-time
Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.22B	USD	Point-in-time
Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.93B	USD	Point-in-time
Cash and cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29B	USD	Point-in-time
Cash and cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.51B	USD	Point-in-time
Cash and cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.22B	USD	Point-in-time
Cash and cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.93B	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	$239.00M	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	$321.00M	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	$240.00M	USD	Annual
Interest	`InterestPaidNet`	$78.00M	USD	Annual
Interest	`InterestPaidNet`	$93.00M	USD	Annual
Interest	`InterestPaidNet`	$112.00M	USD	Annual
Fair value of assets acquired	`FairValueOfAssetsAcquired`	-	USD	Annual
Fair value of assets acquired	`FairValueOfAssetsAcquired`	$1.34B	USD	Annual
Fair value of assets acquired	`FairValueOfAssetsAcquired`	-	USD	Annual
Fair value of contingent consideration liabilities	`FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities`	-	USD	Annual
Fair value of contingent consideration liabilities	`FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities`	-	USD	Annual
Fair value of contingent consideration liabilities	`FairValueOfContingentConsiderationLiabilitiesAssumedInNoncashInvestingOrFinancingActivities`	$40.00M	USD	Annual
Fair value of liabilities assumed	`LiabilitiesAssumed1`	-	USD	Annual
Fair value of liabilities assumed	`LiabilitiesAssumed1`	-	USD	Annual
Fair value of liabilities assumed	`LiabilitiesAssumed1`	$545.00M	USD	Annual
Net cash paid in business combinations	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Net cash paid in business combinations	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$755.00M	USD	Annual
Net cash paid in business combinations	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Common stock issued in exchange for convertible senior notes	`NotesIssued1`	$131.00M	USD	Annual
Common stock issued in exchange for convertible senior notes	`NotesIssued1`	-	USD	Annual
Common stock issued in exchange for convertible senior notes	`NotesIssued1`	-	USD	Annual
Component of convertible senior notes allocated to additional paid-in capital, net of income taxes	`NotesIssuedFairValueAdjustmentIncreaseDecrease`	$-23.00M	USD	Annual
Component of convertible senior notes allocated to additional paid-in capital, net of income taxes	`NotesIssuedFairValueAdjustmentIncreaseDecrease`	-	USD	Annual
Component of convertible senior notes allocated to additional paid-in capital, net of income taxes	`NotesIssuedFairValueAdjustmentIncreaseDecrease`	-	USD	Annual
Net increase to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	-	USD	Annual
Net increase to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	-	USD	Annual
Net increase to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$108.00M	USD	Annual
Common stock used for stock-based compensation	`StockIssued1`	$7.00M	USD	Annual
Common stock used for stock-based compensation	`StockIssued1`	$6.00M	USD	Annual
Common stock used for stock-based compensation	`StockIssued1`	$8.00M	USD	Annual
Common stock purchases not settled at end of period	`CommonStockPurchasesNotSettledAtEndOfPeriod`	$7.00M	USD	Annual
Common stock purchases not settled at end of period	`CommonStockPurchasesNotSettledAtEndOfPeriod`	$6.00M	USD	Annual
Common stock purchases not settled at end of period	`CommonStockPurchasesNotSettledAtEndOfPeriod`	-	USD	Annual
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Decrease in carrying amount of assets	`IncreaseDecreaseinCarryingAmountofAssets`	-	USD	Annual
Decrease in carrying amount of assets	`IncreaseDecreaseinCarryingAmountofAssets`	$-327.00M	USD	Annual
Decrease in carrying amount of assets	`IncreaseDecreaseinCarryingAmountofAssets`	-	USD	Annual
Decrease in carrying amount of liabilities	`GainLossonDispositionofLiabilities`	$85.00M	USD	Annual
Decrease in carrying amount of liabilities	`GainLossonDispositionofLiabilities`	-	USD	Annual
Decrease in carrying amount of liabilities	`GainLossonDispositionofLiabilities`	-	USD	Annual
Transaction costs	`DispositionofBusinessTransactionCosts`	$15.00M	USD	Annual
Transaction costs	`DispositionofBusinessTransactionCosts`	-	USD	Annual
Transaction costs	`DispositionofBusinessTransactionCosts`	-	USD	Annual
Cash received from buyers	`DispositionofBusinessReceivablefromBuyer`	-	USD	Annual
Cash received from buyers	`DispositionofBusinessReceivablefromBuyer`	$242.00M	USD	Annual
Cash received from buyers	`DispositionofBusinessReceivablefromBuyer`	-	USD	Annual
Loss on sale of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	$-15.00M	USD	Annual
Loss on sale of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	Annual
Loss on sale of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	Annual

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance (in shares)	`SharesOutstanding`	59.30M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	62.10M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	61.90M	shares	Point-in-time
Beginning Balance	`StockholdersEquity`	$1.96B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$1.34B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$1.65B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$2.10B	USD	Point-in-time
Net income	`NetIncomeLoss`	$673.00M	USD	Annual
Net income	`NetIncomeLoss`	$737.00M	USD	Annual
Net income	`NetIncomeLoss`	$707.00M	USD	Annual
Common stock purchases	`StockRepurchasedDuringPeriodValue`	$54.00M	USD	Annual
Common stock purchases	`StockRepurchasedDuringPeriodValue`	$605.00M	USD	Annual
Termination of warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-30.00M	USD	Annual
Termination of warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-550.00M	USD	Annual
Termination of warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-514.00M	USD	Annual
Exchange of convertible senior notes	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	-	USD	Annual
Exchange of convertible senior notes	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	-	USD	Annual
Exchange of convertible senior notes	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$108.00M	USD	Annual
Conversion of convertible senior notes	`StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments`	$4.00M	USD	Annual
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$33.00M	USD	Annual
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$12.00M	USD	Annual
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-2.00M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$37.00M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$47.00M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$65.00M	USD	Annual
Ending Balance (in shares)	`SharesOutstanding`	59.30M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	62.10M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	61.90M	shares	Point-in-time
Ending Balance	`StockholdersEquity`	$1.65B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$1.96B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$1.34B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$2.10B	USD	Point-in-time

Comprehensive Income 15 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$673.00M	USD	Annual
Net income	`NetIncomeLoss`	$737.00M	USD	Annual
Net income	`NetIncomeLoss`	$707.00M	USD	Annual
Unrealized investment income (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$44.00M	USD	Annual
Unrealized investment income (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-3.00M	USD	Annual
Unrealized investment income (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$16.00M	USD	Annual
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$11.00M	USD	Annual
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$4.00M	USD	Annual
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-1.00M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$33.00M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$12.00M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-2.00M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$706.00M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$705.00M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$749.00M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.